EUVIMEDEUVIMED entdecken
Crossref

Advances in the Research of Bispecific Antibodies in Immunotherapy for Multiple Myeloma

浩 利

Journal of Clinical Personalized Medicine · 2026 · 05 (03) · 324-333

DOI: 10.12677/jcpm.2026.53213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Personalized Medicine, 2026. Verfasst von 浩 利. Die Arbeit nennt 47 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

利, 浩. (2026). Advances in the Research of Bispecific Antibodies in Immunotherapy for Multiple Myeloma. Journal of Clinical Personalized Medicine, 05(03), 324-333. https://doi.org/10.12677/jcpm.2026.53213

Vancouver

利 浩. Advances in the Research of Bispecific Antibodies in Immunotherapy for Multiple Myeloma. Journal of Clinical Personalized Medicine. 2026;05(03):324-333. doi:10.12677/jcpm.2026.53213

BibTeX
@article{2026,
  author = {利, 浩},
  title = {Advances in the Research of Bispecific Antibodies in Immunotherapy for Multiple Myeloma},
  journal = {Journal of Clinical Personalized Medicine},
  year = {2026},
  volume = {05},
  number = {03},
  pages = {324--333},
  doi = {10.12677/jcpm.2026.53213}
}
Kostenlos starten →